Topic:
Manufacturing
Latest Headlines
Latest Headlines
Sanofi to relaunch Shan5 in 2013
Sanofi ($SNY) subsidiary Shantha Biotech plans to relaunch the company's pentavalent Shan5 vaccine in 2013. The vaccine was removed from the World Health Organization's prequalification list...
GE jumps in to biologics, vaccine manufacturing game
GE Healthcare is gearing up to give established pharma companies competition in emerging markets. The company announced this week it's teaming with German engineering firm M+W Group to help...
Novartis opens doors to $1B vaccine plant
Federal officials have cleared Novartis' North Carolina-based vaccine plant for production of flu vaccines in the event of an influenza outbreak. The $1 billion plant is the first in the U.S. to...
China preps for big push into vaccine market
After years of supplying shots to those within its own borders, China-based vaccine makers are preparing to compete with Western rivals for a slice of the $25.3 billion worldwide vaccine market. In...
